See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
DepoProvera, Provera
What is Medroxyprogesterone Acetate? This is a contraceptive agent also used with endometrial carcinoma or renal carcinoma; secondary amenorrhea or abnormal uterine bleeding due to hormonal imbalance; reduction of endometrial hyperplasia in nonhysterectomized postmenopausal women receiving conjugated estrogens.
6 patients in the community are taking or have taken Medroxyprogesterone Acetate.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Other | 5 | 83% |
| General health | 1 | 16% |
Based on the patients currently taking Medroxyprogesterone Acetate.
How long current patients have been taking Medroxyprogesterone Acetate or how long patients were taking Medroxyprogesterone Acetate before stopping.
Results from 3 patient evaluations. See the overall results and all individual evaluations.
| Major | 100% | 3 |
|---|
Other
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 33% | 1 |
| Mild | 0% | 0 |
| None | 67% | 2 |
Top reported side-effects include: Depression, Vaginal Dryness
Summary results are based on 3 individual responses. For more information, see overall results for Adherence, Burden and Cost.